Cargando…
Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844178/ https://www.ncbi.nlm.nih.gov/pubmed/29523130 http://dx.doi.org/10.1186/s12933-018-0676-1 |
| _version_ | 1783305214011375616 |
|---|---|
| author | Zou, Honghong Zhou, Baoqin Xu, Gaosi |
| author_facet | Zou, Honghong Zhou, Baoqin Xu, Gaosi |
| author_sort | Zou, Honghong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5844178 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58441782018-03-14 Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease Zou, Honghong Zhou, Baoqin Xu, Gaosi Cardiovasc Diabetol Correction BioMed Central 2018-03-09 /pmc/articles/PMC5844178/ /pubmed/29523130 http://dx.doi.org/10.1186/s12933-018-0676-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Zou, Honghong Zhou, Baoqin Xu, Gaosi Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease |
| title | Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease |
| title_full | Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease |
| title_fullStr | Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease |
| title_full_unstemmed | Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease |
| title_short | Correction to: SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease |
| title_sort | correction to: sglt2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844178/ https://www.ncbi.nlm.nih.gov/pubmed/29523130 http://dx.doi.org/10.1186/s12933-018-0676-1 |
| work_keys_str_mv | AT zouhonghong correctiontosglt2inhibitorsanovelchoiceforthecombinationtherapyindiabetickidneydisease AT zhoubaoqin correctiontosglt2inhibitorsanovelchoiceforthecombinationtherapyindiabetickidneydisease AT xugaosi correctiontosglt2inhibitorsanovelchoiceforthecombinationtherapyindiabetickidneydisease |